Gendicine approval in India delayed?
As contrary to previous expectations, Gendicine's approval in India has not yet happened.
"HUBEI PROVINCE, China -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine([R]), the world's first commercialized gene therapy medicine for the treatment of cancer, announced today that Gendicine([R]) has passed major milestones in its clinical trials in India and is expected to be approved for sale in India in 2008.
